Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration
Authors:
- Juan M. ArandaJAJuan M. Aranda
- Gregory W. WooGWGregory W. Woo
- Jamie B. ContiJCJamie B. Conti
- Richard S. SchofieldRSRichard S. Schofield
- C. Richard ContiCCC. Richard Conti
- James A. HillJHJames A. Hill
- 1 April 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (7) , 889-891
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004
- Dose of metoprolol CR/XL and clinical outcomes in patients with heart failureJACC, 2002
- Cardiac Resynchronization in Chronic Heart FailureNew England Journal of Medicine, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costsJACC, 2001
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993